How Malvern Panalytical has partnered with LGC to help pave the way for better characterized nanomaterials

LGC was an early adopter of NTA technology, and has worked consistently closely with the NanoSight product development team of scientists in improving NTA software so that it allows for more accurate measurement of nanoparticle populations in the high serum concentrations which reflect those encountered in toxicology models.  LGC was also chosen by Malvern Panalytical to beta-test the flow-based concentration upgrade designed specifically for this purpose. Phil Vincent, Development Scientist at Malvern Panalytical says, “LGC has provided expert application support to aid the development of our nanoparticle tracking technology. Their forward-thinking approach has made them willing candidates for beta testing new concepts and providing valuable feedback which has helped shape parts of our technology.”

Connexion

Not registered yet? Create an account